2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

Published:2016-09 Issue: Volume:27 Page:v119-v133
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Roila F.,Molassiotis A.,Herrstedt J.,Aapro M.,Gralla R.J.,Bruera E.,Clark-Snow R.A.,Dupuis L.L.,Einhorn L.H.,Feyer P.,Hesketh P.J.,Jordan K.,Olver I.,Rapoport B.L.,Roscoe J.,Ruhlmann C.H.,Walsh D.,Warr D.,van der Wetering M.

Funder

MASCC

ESMO

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/suppl_5/v119/6678054/mdw270.pdf

Reference68 articles.

1. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference;Roila;Ann Oncol,2010

2. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update;Grunberg;Support Care Cancer,2005

3. Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review;Jordan;Ann Oncol,2015

4. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol—EASE;Grunberg;J Clin Oncol,2011

5. Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial;Saito;Ann Oncol,2013

Cited by 493 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A global review of acupuncture and moxibustion recommendations in guidelines/expert consensus for chemotherapy- and/or radiotherapy-induced nausea and/or vomiting;World Journal of Acupuncture - Moxibustion;2024-09

2. Impact of oncology pharmacy services on the management of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis;American Journal of Health-System Pharmacy;2024-08-28

3. Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial;Journal of Clinical Oncology;2024-08-16

4. Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy;JAMA Network Open;2024-08-06

5. Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3